The Drug Controller General of India (DCGI) has suspended the approval for PresVu, a drug that its maker Entod Pharmaceuticals had claimed can reduce the dependence on wearing glasses in adults suffering from a condition called presbyopia. The drug regulator debarred the company from manufacturing and marketing it, citing unapproved claims. However, the Entod CEO Nikkhil Masurkar responded to the decision stating, “The suspension order makes no reference to any specific violation of the Drugs and Cosmetics Act, and we have decided to challenge this suspension in court to seek justice.”
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/y9ljfAu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment